Managing febrile neutropenia in the UK in 2020

Arch Dis Child Educ Pract Ed. 2022 Apr;107(2):127-130. doi: 10.1136/archdischild-2020-319886. Epub 2021 Jun 3.

Authors

Sheena Guram¹, Aditi Vedi²

Affiliations

¹ Department of Paediatric Haematology and Oncology, University College London Hospitals NHS Foundation Trust, London, UK s.guram@nhs.net.
² Department of Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK.

PMID: 34083214
DOI: 10.1136/archdischild-2020-319886

No abstract available

Keywords: Adolescent Health; Mortality.

MeSH terms

Anti-Bacterial Agents / therapeutic use
Febrile Neutropenia* / diagnosis
Febrile Neutropenia* / drug therapy
Humans
Neoplasms*
United Kingdom

Substances

Anti-Bacterial Agents